Terms: = Breast cancer AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5
19 results:
1. Implications for health system resilience: Quantifying the impact of the COVID-19-related stay at home orders on cancer screenings and diagnoses in southeastern North Carolina, USA.
Carroll R; Duea SR; Prentice CR
Prev Med; 2022 May; 158():107010. PubMed ID: 35305996
[TBL] [Abstract] [Full Text] [Related]
2. Second invasive breast cancers in patients treated with breast-conserving therapy.
Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
[TBL] [Abstract] [Full Text] [Related]
3. Primate-specific histone variants.
Ding D; Nguyen TT; Pang MYH; Ishibashi T
Genome; 2021 Apr; 64(4):337-346. PubMed ID: 33245240
[TBL] [Abstract] [Full Text] [Related]
4. Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity.
Umamaheswaran G; Kadambari D; Muthuvel SK; Kalaivani S; Devi J; Damodaran SE; Pradhan SC; Dubashi B; Dkhar SA; Adithan C
Breast Cancer Res Treat; 2020 Jul; 182(1):147-158. PubMed ID: 32385792
[TBL] [Abstract] [Full Text] [Related]
5. Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7-H5 and their relationship with cancer prognosis.
Zhong C; Lang Q; Yu J; Wu S; Xu F; Tian Y
Clin Exp Immunol; 2020 Apr; 200(1):12-21. PubMed ID: 31901178
[TBL] [Abstract] [Full Text] [Related]
6. Investigation of binding mechanism and downregulation of elacestrant for wild and L536S mutant estrogen receptor-α through molecular dynamics simulation and binding free energy analysis.
Chinnasamy K; Saravanan M; Poomani K
J Comput Chem; 2020 Jan; 41(2):97-109. PubMed ID: 31602686
[TBL] [Abstract] [Full Text] [Related]
7. Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.
Janakiram M; Chinai JM; Fineberg S; Fiser A; Montagna C; Medavarapu R; Castano E; Jeon H; Ohaegbulam KC; Zhao R; Zhao A; Almo SC; Sparano JA; Zang X
Clin Cancer Res; 2015 May; 21(10):2359-66. PubMed ID: 25549724
[TBL] [Abstract] [Full Text] [Related]
8. DNA methylation profiling in the Carolina breast cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.
Conway K; Edmiston SN; May R; Kuan PF; Chu H; Bryant C; Tse CK; Swift-Scanlan T; Geradts J; Troester MA; Millikan RC
Breast Cancer Res; 2014 Oct; 16(5):450. PubMed ID: 25287138
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of human LOX-12 as a serum marker for breast cancer.
Singh AK; Kant S; Parshad R; Banerjee N; Dey S
Biochem Biophys Res Commun; 2011 Oct; 414(2):304-8. PubMed ID: 21945939
[TBL] [Abstract] [Full Text] [Related]
10. Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.
Shukla J; Sharma U; Kar R; Varma IK; Juyal S; Jagannathan NR; Bandopadhyaya GP
Nanomedicine (Lond); 2009 Dec; 4(8):895-902. PubMed ID: 19958226
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
[TBL] [Abstract] [Full Text] [Related]
12. Apoptosis/necrosis switch in two different cancer cell lines: influence of benzoquinone- and hydrogen peroxide-induced oxidative stress intensity, and glutathione.
Baigi MG; Brault L; Néguesque A; Beley M; Hilali RE; Gaüzère F; Bagrel D
Toxicol In Vitro; 2008 Sep; 22(6):1547-54. PubMed ID: 18619529
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of apoptosis-induction by newly synthesized phthalazine derivatives in breast cancer cell lines.
Arif JM; Kunhi M; Bekhit AA; Subramanian MP; Al-Hussein K; Aboul-Enein HY; Al-Khodairy FM
Asian Pac J Cancer Prev; 2006; 7(2):249-52. PubMed ID: 16839218
[TBL] [Abstract] [Full Text] [Related]
14. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.
Brem R; Cox DG; Chapot B; Moullan N; Romestaing P; Gérard JP; Pisani P; Hall J
Carcinogenesis; 2006 Dec; 27(12):2469-74. PubMed ID: 16829685
[TBL] [Abstract] [Full Text] [Related]
15. The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes.
Yamamoto Y; Wada O; Suzawa M; Yogiashi Y; Yano T; Kato S; Yanagisawa J
J Biol Chem; 2001 Nov; 276(46):42684-91. PubMed ID: 11553641
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract] [Full Text] [Related]
17. Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells.
Duque PM; Alonso C; Sánchez-Prieto R; Lleonart M; Martínez C; de Buitrago GG; Cano A; Quintanilla M; Ramon y Cajal S
Cancer Gene Ther; 1999; 6(6):554-63. PubMed ID: 10608352
[TBL] [Abstract] [Full Text] [Related]
18. Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast.
Mommers EC; Leonhart AM; von Mensdorff-Pouilly S; Schol DJ; Hilgers J; Meijer CJ; Baak JP; van Diest PJ
Int J Cancer; 1999 Oct; 84(5):466-9. PubMed ID: 10502721
[TBL] [Abstract] [Full Text] [Related]
19. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
Mathieu M; Vignon F; Capony F; Rochefort H
Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
[TBL] [Abstract] [Full Text] [Related]
